Moderna on Tuesday applied for a so-called “biologics license” for its COVID-19 vaccine, a step up from its current emergency use authorization that would open the shot to interstate commerce and allow the drugmaker to market it directly to consumers. The company’s mRNA vaccine was approved for emergency use by the Food and Drug Administration…